Basic Information
| LncRNA/CircRNA Name | SNHG5 |
| Synonyms | SNHG5, C6orf160, LINC00044, NCRNA00044, U50HG, bA33E24.2 |
| Region | GRCh38_6:85660950-85678736 |
| Ensemble | ENSG00000203875 |
| Refseq | NR_003038 |
Classification Information
| Regulatory Mechanism | Biological Function | Clinical Application | |||
|---|---|---|---|---|---|
| TF | Immune | Survival | |||
| Enhancer | Apoptosis | Drug | |||
| Variant | Cell Growth | Circulating | |||
| MiRNA | EMT | Metastasis | |||
| Methylation | Coding Ability | Recurrence |
Cancer&Entry Information
| Cancer Name | malignant melanoma |
| ICD-0-3 | NA |
| Methods | qPCR etc. |
| Sample | serum |
| Expression Pattern | up-regulated |
| Function Description | The serum SNHG5 levels in all MM cases, all MM stages, SCC and NS samples are shown in Fig. 1. The serum levels of SNHG5 were significantly higher in the patients with MM than in the normal subjects and patients with SCC. The serum levels of SNHG5 for each MM stage were significantly higher than those in the NS, especially for stage 4. |
| Pubmed ID | 26440365 |
| Year | 2016 |
| Title | Serum long non-coding RNA, snoRNA host gene 5 level as a new tumor marker of malignant melanoma. |
External Links
| Links for SNHG5 | GenBank HGNC NONCODE |
| Links for malignant melanoma | OMIM COSMIC |